Thank you for standing by. This is the conference operator. Welcome to the Tiptree First Quarter 2018 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Sandra Bell, Chief Financial Officer. Please go ahead.

Good morning, and welcome to our first quarter 2018 earnings call. We are joined today by our Executive Chairman, Michael Barnes; and CEO, Jonathan Ilany. We have posted the earnings release and presentation on our website at tiptreeinc.com. Our remarks today are qualified in their entirety by the disclaimers on page 1 of the presentation. This presentation supplements our SEC filings and is provided solely for information purposes. Throughout the presentation, we make forward-looking statements. Our businesses are subject to risks and uncertainties which are outlined in our SEC filings and which could impact our expectations of future results. Except as required by securities law, we undertake no obligation to update any forward-looking statement. We use non-GAAP measures which we believe provide supplemental information about our business and are useful to investors. As these measures are not GAAP, they should not be used as a substitute for GAAP disclosures. The appendix provides a reconciliation of each of these measures to their GAAP equivalent. With that, we will turn the call over to Michael.

Thank you, Sandra, and good morning, everyone. Through the first four months of 2018, we have executed on several of our strategic objectives. We closed the sale of Care to Invesque, resulting in a $0.91 per share increase to book value. Consistent with our goal of simplifying our story and our corporate structure, we eliminated our dual-class structure in April. And effective May 4, we refinanced our corporate loan facility, which, combined with cash on the balance sheet, gives us close to $100 million of capital available to invest in support of our growth initiatives. As we announced in March, we are executing on a share buyback plan of up to $20 million. These buybacks reflect our confidence in the underlying businesses. Buying our own stock at deep discounts to both book value and intrinsic value will remain a lever for creating long-term value for shareholders. Given the consistent cash flows generated at our companies and our growth in book value per share, we have announced a 16.7% increase in our dividend to $0.035 beginning this quarter. From an operating perspective, our first quarter results were dominated by three key factors: growth in our specialty insurance business, the sale of our Care business and continued volatility in our assets held at fair value, including equity investments. We are beginning to see significant traction from our strategy to grow our specialty insurance business. Gross written premiums were up 21% from a year ago while net return premiums were up 27%, driven by improvements in all product lines. We are continuing to expand on multiple fronts through product offerings with distribution partners, and geographically, with the establishment of our European subsidiary. All of these positive results occurred while maintaining our combined ratio in the low 90s. As premiums grow, so does our investment portfolio, which grew 15% from first quarter 2017. Excluding the volatility in equities, our investment income improved over last year, primarily as a result of the growth in the portfolio. Having closed the sale of Care, we now own 16.4 million Invesque shares. We remain excited about the long-term prospects for the senior living business and in the capabilities of Invesque's management team. In the last six months, Invesque has executed multiple accretive transactions, which also further diversifies their senior care investment base. While we may experience some mark-to-market volatility from time to time on the shares, we expect to continue to receive steady dividends in line with Invesque's growth. With that, I'll pass it to Sandra, who will take you through the financials in more detail.

Thank you, Michael. On page 4, we highlight the company's key metrics for the first quarter of 2018. Net income was $29 million, including an approximate $34 million after-tax gain on our sale of Care. This gain is recorded in discontinued operations and is the largest contributor to our year-over-year increase in net income. Our earnings from continuing operations were positively impacted by growth in our specialty insurance underwriting operations. We are beginning to see the impact of our strategic decision to extend duration of the contacts -- contracts, both on the balance sheet and now in the income statement. Within the quarter, we received our first two months of dividends from Invesque, which we expect to be approximately $3 million per quarter going forward. Offsetting these positive contributions were year-over-year reductions in cash distributions from the sale of CLO subnotes and unrealized losses on equities, including our Invesque shares. Book value per share increased to $10.59, up $0.44 from the prior year and $0.62 from year-end 2017, as the gain on sale of Care and improvements in specialty insurance underwriting results overcame any negative factors. The effective tax rate for the quarter was 27.1%, a reduction from prior year given the new tax laws. This was slightly higher than our expected normalized rate for the year of approximately 20%, primarily driven by state tax associated with the Care gain. On the bottom left, you can see how our total capital is currently allocated across our businesses, with approximately 70% concentrated in the insurance sector. Trailing 12 months normalized EBITDA was $57.4 million, down $4.6 million, while insurance normalized EBITDA was up over 7.3% from growth in both credit and warranty products and our corporate expenses were down $6.8 million. The impact of the sale of the CLO subnotes more…

Thanks, Sandra. So to provide a quick summary, in the first four months of 2018, we executed on several strategic objectives to expand our insurance business and simplify our corporate structure. We also raised additional capital at lower cost to supplement our balance sheet cash to support our long-term growth objectives. We expect to continue to grow our insurance investment portfolio in line with the business and to leverage Tiptree's investment expertise to increase the total return of the insurance portfolio over the long term. Within Tiptree Capital, we expect to reinvest capital as opportunities arise. We believe our strategic efforts to better position the company for growth and stable operating performance should ultimately allow us to deliver Tiptree's intrinsic value for investors. With that, we can open the line for questions.

[Operator Instructions] Our first question comes from Andrew Cowen with Community Capital.

Really nice quarter. It's nice to see the simplification. Just to go through it. So is it right to read that the investment portfolio for the insurance, the float is averaging around a 4% yield or so?

Yes.

Okay.

That's about right, Andrew. That's exactly right.

Great. Okay. And the EBITDA number you're giving now of -- the adjusted EBITDA of $5.3 million, so that is not including -- so that below that line would be the dividends you received from Invesque?

No. Adjusted EBITDA, it would include the dividends from Invesque, but it also includes the mark-to-market and stock-based compensation. Normalized EBITDA, which we show on the second page of the presentation, it excludes unrealized mark-to-market and it excludes stock-based compensation. So that's the higher number.

Is that on Page 2? I see there's no Page 2. Page 3, you mean?

Page 3. Correct, yes.

Page 3. Yes, sorry.

So the higher number.

So Andrew, one of the questions, and I know this, something that we've had discussions on, is kind of the normalized EBITDA or the earnings sort of ability. If you look at page -- I'm sorry, I apologize. It's Page 5 of the investor presentation. You'll see at the bottom of that, where we show return on total capital, normalized EBITDA, broken down by segment. And you'll see there is what we see as kind of now a consistent earnings capability of our businesses.

That's very helpful. Okay.

So I think that's what you should be focused on in terms of our -- sort of the continuing, ongoing sort of earnings of this business.

So that's the $8.6 million. Hold on. That's the insurance. I might be looking at the wrong figure here.

Andrew, it's Page 4...

I apologize for that.

Sorry, I apologize. It's $8.9 million for the quarter and $57.4 million for the trailing 12 months.

There you go.

That's extremely helpful. Okay. So then you throw in a -- like, a 27% tax rate. Do you anticipate that tax rate going down?

Yes. It'll be about 20% because of the dividends received deduction on the Invesque dividends.

Okay. Right. So we're looking at, then, over $1 a share of cash earnings, somewhere around there, if you tax that EBITDA rate, somewhere around there. Okay.

That would be accurate.

Okay. One other question. What's the new share count after the Tiptree, the conversion of the Class B shares?

37.9 million.

That's fully diluted?

That is outstanding.

[Operator Instructions] There are no further questions registered at this time. I would like to turn the conference back over at Sandra Bell for any closing remarks.

Thank you, Claudia, and thanks, everyone, for joining us today. If you have any questions, please feel free to reach out to me directly. This concludes our first quarter conference call.

This concludes today's conference call. You may disconnect your lines. Thank you for participating, and have a pleasant day.